Net profit of Jubilant Pharmova rose 7432.81% to Rs 482.10 crore in the quarter ended June 2024 as against Rs 6.40 crore during the previous quarter ended June 2023. Sales rose 9.82% to Rs 1720.40 crore in the quarter ended June 2024 as against Rs 1566.50 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1720.401566.50 10 OPM %14.6210.74 - PBDT194.50114.90 69 PBT103.8025.20 312 NP482.106.40 7433 Powered by Capital Market - Live News

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 19 July 2024.Powered by Capital Market - Live News

Jubilant Pharmova announced that Jubilant Pharma Holdings Inc., USA (JPHI), a wholly owned subsidiary of Jubilant Pharma (JPL), and a wholly owned subsidiary of the Company has completed the voluntary prepayment of term loan of USD 75 million (Rs 626 crore) on 24 June 2024. As on 31 March 2024, Jubilant Pharmova reported gross debt at Rs. 3,414 crore and net debt at Rs. 2,457 crore on a consolidated basis.Powered by Capital Market - Live News

Jubilant Pharmova announced that the United States Food and Drug Administration (USFDA) has concluded the audit of the Jubilant HollisterStier General Partnership (JHSGP)`s contract manufacturing facility located in Montreal, Canada. The USFDA has issued 15 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations. JHSGP is a subsidiary of Jubilant HollisterStier Inc., USA, a step down subsidiary of Jubilant Pharma, Singapore, and a wholly owned subsidiary of the Company. Powered by Capital Market - Live News

Jubilant Pharmova announced that the United States Food and Drug Administration (USFDA) has concluded an eight day audit of the Jubilant HollisterStier LLC`s contract manufacturing facility located in Spokane, Washington (USA). The USFDA has issued 3 observations pursuant to the completion of audit. The company will submit an action plan on the observations.Jubilant HollisterStier LLC is a subsidiary of Jubilant Pharma Holding Inc., which is a subsidiary of Jubilant Pharma, Singapore, a wholly owned subsidiary of the company.Powered by Capital Market - Live News